Campylobacter Infections Clinical Trial
Official title:
Recurrent Campylobacter Bacteraemia in Immunocompromised Patients: a Retrospective Nationwide Study in France, 2000-2025
Some rare cases of recurrent Campylobacter bacteraemia (RCB) exist with relapses months to years after an effective treatment and a negativation of all bacterial samples. As of today, only around 20 cases have been described in the international literature for the last 30 years. The cases are likely highly underreported. No study describes those recurrent Campylobacter bacteraemias at the scale of a country. The aim of this multicentre, nationwide, retrospective study is to describe their precise epidemiology in France for the last 25 years, the immune profile of the patients, the specificities of the bacteria involved, the treatments received and the evolution of these infections. The perspective is to propose a standardization of the medical care of those patients mainly by describing the effective treatments and the explorations of the immune system which should be considered.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03683667 -
Protein Plus: Improving Infant Growth Through Diet and Enteric Health
|
Phase 2/Phase 3 | |
Completed |
NCT03266068 -
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
|
||
Active, not recruiting |
NCT02040922 -
Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota
|
N/A | |
Recruiting |
NCT01048112 -
Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
|
Phase 1 | |
Recruiting |
NCT06425250 -
Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study
|
||
Completed |
NCT04182490 -
LMN-101 in a Campylobacter Human Challenge Model
|
Phase 2 | |
Active, not recruiting |
NCT00434798 -
Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
|
Phase 1 | |
Completed |
NCT02884752 -
Retrospective Study of Bone Infection Due to Campylobacter Spp
|
N/A |